Pivotal Immune-Bridging Study of the Inactivated Whole-Virus COVID-19 Vaccine VLA2001: A Phase 3, Randomized Controlled Clinical Trial in Adults Using Adenoviral Vector Vaccine AZD1222 as a Comparator
SSRN Electronic Journal (2022) - Comments
doi: 10.2139/ssrn.4125252  issn: 1556-5068 

Rajeka Lazarus, Benedicte Querton, Irena Corbic, Juan Carlos Jaramillo, Katrin Dubischar, Michael Krammer, Petronela Weisova, Romana Hochreiter, Susanne Eder-Lingelbach, Christian Taucher, Adam Finn